ARTICLE | Company News
Zafgen names Hatfield CEO
October 11, 2017 12:13 AM UTC
Metabolic disease company Zafgen Inc. (NASDAQ:ZFGN) hired Jeffrey Hatfield as CEO. He replaces Thomas Hughes, who will remain president and become CSO.
Hatfield was CEO of Vitae Pharmaceuticals Inc., which Allergan plc (NYSE:AGN) acquired in 2016 (see BioCentury Extra, Sept. 14, 2016)...